Premium
Long‐term changes in adipose tissue gene expression following bariatric surgery
Author(s) -
Kerr A. G.,
Andersson D. P.,
Rydén M.,
Arner P.,
Dahlman I.
Publication year - 2020
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.13066
Subject(s) - medicine , adipose tissue , adipokine , weight loss , adipocyte , white adipose tissue , gene expression profiling , endocrinology , gene expression , transcriptome , adiponectin , surgery , obesity , gene , leptin , insulin resistance , biology , genetics
Objective Patients undergoing bariatric surgery present long‐term metabolic improvements and reduced type 2 diabetes risk, despite long‐term weight regain. We hypothesized that part of these protective effects could be linked to altered gene expression in white adipose tissue (WAT). Methods Transcriptomic profiling by gene microarray was performed in abdominal subcutaneous WAT from women before ( n = 50) and two ( n = 49) and five ( n = 38) years after Roux‐en‐Y gastric bypass (RYGB) surgery as well as in 28 age‐matched nonoperated women. Results In the obese women, the average body weight decrease was 38 kg 2 years postsurgery followed by an 8 kg weight regain between 2 and 5 years. Most of the long‐term changes in WAT gene expression occurred during the first 2 years. However, a subset of genes encoding proteins involved in inflammation displayed a continued decrease between baseline, 2 and 5 years, respectively; that is an expression pattern independent of body weight regain. Expression of 71 of these genes correlated with measurements of adipocyte morphology or serum adipokine levels. Conclusion The continuous improvement in WAT inflammatory gene expression, despite body weight relapse, may contribute to the sustained effects on adipose morphology after bariatric surgery.